Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2272 participants.
Also called NCT01841242
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 2,272 participants
- Registry
-
NCT01841242 -
2012-000803-33
-
- Other papers using this trial's data
- Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices: A Prospective Randomized Study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT01841242. Randomized; no masking; primary purpose prevention. Start 2013-04-23 (actual); primary completion 2021-01-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
- Acronym
- CHLOVIS
- Condition
- Heart Failure
- Condition
- Arrhythmia
- Intervention (Drug)
- alcoholic povidone iodine
- Intervention (Drug)
- alcoholic chlorhexidine
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Collaborator
- Ministry of Health, France
- Collaborator
- C. R. Bard
Record details
- Record id
cardio:ct-nct01841242- Content hash
237ffff0aa5e77788654843f554cbc4e977dfc7ec083ac236d3c57a964079232